CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 857 of 859
Non-Antibody Products
Page 857 of 859
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Zuclopenthixol | A dopamine receptor antagonist (Kis = 9.8 and 1.5 nM for D1 and D2 recepto… | 250 mg | 24961-250 | More Info |
| Zuclopenthixol | A dopamine receptor antagonist (Kis = 9.8 and 1.5 nM for D1 and D2 recepto… | 500 mg | 24961-500 | More Info |
| Z-VAD-AMC (acetate) | A caspase-1 fluorogenic substrate; upon enzymatic cleavage, AMC is release… | 1 mg | 27142-1 | More Info |
| Z-VAD-AMC (acetate) | A caspase-1 fluorogenic substrate; upon enzymatic cleavage, AMC is release… | 5 mg | 27142-5 | More Info |
| Z-VAD-AMC (acetate) | A caspase-1 fluorogenic substrate; upon enzymatic cleavage, AMC is release… | 500 µg | 27142-500 | More Info |
| Z-VA-DL-D(OMe)-FMK (trifluoroacetate salt) | A pan-caspase inhibitor; inhibits anti-Fas antibody-induced cleavage of ca… | 1 mg | 27421-1 | More Info |
| Z-VA-DL-D(OMe)-FMK (trifluoroacetate salt) | A pan-caspase inhibitor; inhibits anti-Fas antibody-induced cleavage of ca… | 500 µg | 27421-500 | More Info |
| Z-VAD(OH)-FMK | An irreversible tripeptide inhibitor of all caspases; useful in studies in… | 1 mg | 14467-1 | More Info |
| Z-VAD(OH)-FMK | An irreversible tripeptide inhibitor of all caspases; useful in studies in… | 5 mg | 14467-5 | More Info |
| Z-VAD(OH)-FMK | An irreversible tripeptide inhibitor of all caspases; useful in studies in… | 500 µg | 14467-500 | More Info |
| Z-VAD(OMe)-FMK | A cell-permeable, competitive, and irreversible inhibitor of all caspases,… | 1 mg | 14463-1 | More Info |
| Z-VAD(OMe)-FMK | A cell-permeable, competitive, and irreversible inhibitor of all caspases,… | 5 mg | 14463-5 | More Info |
| Z-VDVAD-AFC (trifluoroacetate salt) | A fluorogenic substrate for caspase-2; AFC is released upon enzymatic clea… | 1 mg | 27147-1 | More Info |
| Z-VDVAD-AFC (trifluoroacetate salt) | A fluorogenic substrate for caspase-2; AFC is released upon enzymatic clea… | 5 mg | 27147-5 | More Info |
| Z-VDVAD-AFC (trifluoroacetate salt) | A fluorogenic substrate for caspase-2; AFC is released upon enzymatic clea… | 500 µg | 27147-500 | More Info |
| Z-VDVAD-pNA (trifluoroacetate salt) | A colorimetric caspase-2 substrate; cleavage of the VDVAD peptide sequence… | 1 mg | 27426-1 | More Info |
| Z-VDVAD-pNA (trifluoroacetate salt) | A colorimetric caspase-2 substrate; cleavage of the VDVAD peptide sequence… | 5 mg | 27426-5 | More Info |
| Z-VEID-AFC (trifluoroacetate salt) | A fluorogenic substrate for caspase-6; AFC is released upon enzymatic clea… | 1 mg | 27146-1 | More Info |
| Z-VEID-AFC (trifluoroacetate salt) | A fluorogenic substrate for caspase-6; AFC is released upon enzymatic clea… | 5 mg | 27146-5 | More Info |
| Z-VEID-AFC (trifluoroacetate salt) | A fluorogenic substrate for caspase-6; AFC is released upon enzymatic clea… | 500 µg | 27146-500 | More Info |
| Z-VRPR-FMK (trifluoroacetate salt) | A selective, irreversible inhibitor of the paracaspase MALT1, an endopepti… | 1 mg | 19617-1 | More Info |
| Z-VRPR-FMK (trifluoroacetate salt) | A selective, irreversible inhibitor of the paracaspase MALT1, an endopepti… | 500 µg | 19617-500 | More Info |
| Zymosan A | A TLR2 and dectin-1 activator | 1 g | 21175-1 | More Info |
| Zymosan A | A TLR2 and dectin-1 activator | 250 mg | 21175-250 | More Info |
| Zymosan A | A TLR2 and dectin-1 activator | 500 mg | 21175-500 | More Info |
| Zymostenol | A precursor of cholesterol; an agonist of RORγ (EC50 = 1 µM in… | 10 mg | 26209-10 | More Info |
| Zymostenol | A precursor of cholesterol; an agonist of RORγ (EC50 = 1 µM in… | 25 mg | 26209-25 | More Info |
| Zymostenol | A precursor of cholesterol; an agonist of RORγ (EC50 = 1 µM in… | 5 mg | 26209-5 | More Info |
| Zymostenol | A precursor of cholesterol; an agonist of RORγ (EC50 = 1 µM in… | 50 mg | 26209-50 | More Info |
| Z-YVAD-AFC (trifluoroacetate salt) | A fluorogenic substrate for caspase-1; AFC is released upon enzymatic clea… | 1 mg | 27137-1 | More Info |
| Z-YVAD-AFC (trifluoroacetate salt) | A fluorogenic substrate for caspase-1; AFC is released upon enzymatic clea… | 500 µg | 27137-500 | More Info |
| Z-YVAD-CMK (trifluoroacetate salt) | An inhibitor of caspase-1 and caspase-3; reduces IL-1β and IL-18 secr… | 1 mg | 27435-1 | More Info |
| Z-YVAD-CMK (trifluoroacetate salt) | An inhibitor of caspase-1 and caspase-3; reduces IL-1β and IL-18 secr… | 500 µg | 27435-500 | More Info |
| Z-YVADLD-FMK (trifluoroacetate salt) | A peptide; contains the amino acid sequence YVAD, which is the cleavage si… | 1 mg | 27436-1 | More Info |
| Z-YVADLD-FMK (trifluoroacetate salt) | A peptide; contains the amino acid sequence YVAD, which is the cleavage si… | 500 µg | 27436-500 | More Info |
| 9(Z),11(Z)-Conjugated Linoleic Acid | An isomer of linoleic acid; has been found in milk from cows and other ani… | 10 mg | 24582-10 | More Info |
| 9(Z),11(Z)-Conjugated Linoleic Acid | An isomer of linoleic acid; has been found in milk from cows and other ani… | 25 mg | 24582-25 | More Info |
| 9(Z),11(Z)-Conjugated Linoleic Acid | An isomer of linoleic acid; has been found in milk from cows and other ani… | 5 mg | 24582-5 | More Info |
| 9(Z),11(Z)-Conjugated Linoleic Acid methyl ester | A conjugated linoleic acid methyl ester; has been used as a standard for t… | 25 mg | 24583-25 | More Info |
| 4(Z),7(Z)-Decadienoic Acid | A PUFA; increased in the plasma of patients with an MCAD deficiency | 1 mg | 23516-1 | More Info |
| 4(Z),7(Z)-Decadienoic Acid | A PUFA; increased in the plasma of patients with an MCAD deficiency | 10 mg | 23516-10 | More Info |
| 4(Z),7(Z)-Decadienoic Acid | A PUFA; increased in the plasma of patients with an MCAD deficiency | 25 mg | 23516-25 | More Info |
| 4(Z),7(Z)-Decadienoic Acid | A PUFA; increased in the plasma of patients with an MCAD deficiency | 5 mg | 23516-5 | More Info |
| 4(Z),7(Z)-Decadienoic Acid-d5 | An internal standard for the quantification of 4(Z),7(Z)-decadienoic acid… | 1 mg | 14896-1 | More Info |
| 4(Z),7(Z)-Decadienoic Acid-d5 | An internal standard for the quantification of 4(Z),7(Z)-decadienoic acid… | 100 µg | 14896-100 | More Info |
| 4(Z),7(Z)-Decadienoic Acid-d5 | An internal standard for the quantification of 4(Z),7(Z)-decadienoic acid… | 50 µg | 14896-50 | More Info |
| 4(Z),7(Z)-Decadienoic Acid-d5 | An internal standard for the quantification of 4(Z),7(Z)-decadienoic acid… | 500 µg | 14896-500 | More Info |
| 13Z,16Z-Docosadienoic Acid | A natural ω-6 PUFA; an agonist of FFAR4 (GPR120) that strongly inhib… | 1 mg | 20749-1 | More Info |
| 13Z,16Z-Docosadienoic Acid | A natural ω-6 PUFA; an agonist of FFAR4 (GPR120) that strongly inhib… | 10 mg | 20749-10 | More Info |
| 13Z,16Z-Docosadienoic Acid | A natural ω-6 PUFA; an agonist of FFAR4 (GPR120) that strongly inhib… | 5 mg | 20749-5 | More Info |
| 11(Z),14(Z)-Eicosadienoic Acid | An uncommon, naturally occurring PUFA, inhibits the binding of [3H]-LTB4 t… | 100 mg | 90330-100 | More Info |
| 11(Z),14(Z)-Eicosadienoic Acid | An uncommon, naturally occurring PUFA, inhibits the binding of [3H]-LTB4 t… | 250 mg | 90330-250 | More Info |
| 11(Z),14(Z)-Eicosadienoic Acid | An uncommon, naturally occurring PUFA, inhibits the binding of [3H]-LTB4 t… | 50 mg | 90330-50 | More Info |
| 11(Z),14(Z)-Eicosadienoic Acid | An uncommon, naturally occurring PUFA, inhibits the binding of [3H]-LTB4 t… | 500 mg | 90330-500 | More Info |
| 5(Z),14(Z)-Eicosadienoic Acid | A novel ω-6 C20:2 fatty acid | 1 mg | 10010484-1 | More Info |
| 5(Z),14(Z)-Eicosadienoic Acid | A novel ω-6 C20:2 fatty acid | 100 µg | 10010484-100 | More Info |
| 5(Z),14(Z)-Eicosadienoic Acid | A novel ω-6 C20:2 fatty acid | 500 µg | 10010484-500 | More Info |
| 8(Z),14(Z)-Eicosadienoic Acid | 8(Z),14(Z)-Eicosadienoic acid is an ω-8 C20:2 fatty acid. The presen… | 1 mg | 16854-1 | More Info |
| 8(Z),14(Z)-Eicosadienoic Acid | 8(Z),14(Z)-Eicosadienoic acid is an ω-8 C20:2 fatty acid. The presen… | 100 µg | 16854-100 | More Info |
| 8(Z),14(Z)-Eicosadienoic Acid | 8(Z),14(Z)-Eicosadienoic acid is an ω-8 C20:2 fatty acid. The presen… | 500 µg | 16854-500 | More Info |
| 11(Z),14(Z)-Eicosadienoic Acid Ethanolamide | An ethanolamide-conjugated form of 11(Z),14(Z)-eicosadienoic acid | 1 mg | 31024-1 | More Info |
| 11(Z),14(Z)-Eicosadienoic Acid Ethanolamide | An ethanolamide-conjugated form of 11(Z),14(Z)-eicosadienoic acid | 5 mg | 31024-5 | More Info |
| 11(Z),14(Z)-Eicosadienoic Acid Ethanolamide | An ethanolamide-conjugated form of 11(Z),14(Z)-eicosadienoic acid | 500 µg | 31024-500 | More Info |
| 11(Z),14(Z)-Eicosadienoic Acid methyl ester | A more lipid soluble form of 11(Z),14(Z)-eicosadienoic acid | 10 mg | 20750-10 | More Info |
| 11(Z),14(Z)-Eicosadienoic Acid methyl ester | A more lipid soluble form of 11(Z),14(Z)-eicosadienoic acid | 100 mg | 20750-100 | More Info |
| 11(Z),14(Z)-Eicosadienoic Acid methyl ester | A more lipid soluble form of 11(Z),14(Z)-eicosadienoic acid | 5 mg | 20750-5 | More Info |
| 11(Z),14(Z)-Eicosadienoic Acid methyl ester | A more lipid soluble form of 11(Z),14(Z)-eicosadienoic acid | 50 mg | 20750-50 | More Info |
| 12(Z),15(Z)-Heneicosadienoic Acid | A very long-chain polyunsaturated fatty acid; a positional isomer of henei… | 1 mg | 22594-1 | More Info |
| 12(Z),15(Z)-Heneicosadienoic Acid | A very long-chain polyunsaturated fatty acid; a positional isomer of henei… | 10 mg | 22594-10 | More Info |
| 12(Z),15(Z)-Heneicosadienoic Acid | A very long-chain polyunsaturated fatty acid; a positional isomer of henei… | 5 mg | 22594-5 | More Info |
| 7(Z),11(Z)-Heptacosadiene | Female mating pheromone of D. melanogaster; elicits wing vibrations in mal… | 1 mg | 10012567-1 | More Info |
| 7(Z),11(Z)-Heptacosadiene | Female mating pheromone of D. melanogaster; elicits wing vibrations in mal… | 10 mg | 10012567-10 | More Info |
| 7(Z),11(Z)-Heptacosadiene | Female mating pheromone of D. melanogaster; elicits wing vibrations in mal… | 5 mg | 10012567-5 | More Info |
| 7(Z),11(Z)-Heptacosadiene | Female mating pheromone of D. melanogaster; elicits wing vibrations in mal… | 50 mg | 10012567-50 | More Info |
| ZZL-7 | A SERT-nNOS protein-protein interaction inhibitor; increases in vivo serot… | 10 mg | 38645-10 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile